Compare Revvity Inc (RVTY) vs Sony Group Corp (SONY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Sony Group Corp — how do they compare? Revvity Inc trades at $117.6 (market cap $12.91B), while Sony Group Corp trades at $23.7 (market cap $138.43B). The key difference: Sony Group Corp is far larger — about 10.7× Revvity Inc's market cap, and Sony Group Corp pays the higher dividend (0.67%). Which is the better fit depends on your goals.
| RVTY | SONY | |
|---|---|---|
Market Cap | $12.91B | $138.43B |
Sector | Technology | Technology |
52-Week High | $117.75 | $30.26 |
52-Week Low | $82.26 | $19.32 |
Enterprise Value | $15.23B | $136.35B |
Dividend Yield | 0.24% | 0.67% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.
The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.
Sony's stock trades at $23.54, down 1.18% over 24 hours, with a bullish technical signal from moving averages and a neutral oscillator stance. Recent earnings show mixed quarterly beats, with Q2 2026 EPS of $0.36 exceeding expectations. The company reported strong 2025 fundamentals, including $12.96T revenue and $1.14T net income, though 2026 projections indicate a net loss. Positive sentiment is driven by blockbuster film success, such as Spider-Man: Brand New Day, and a joint venture with TSMC for image sensors, highlighting growth in entertainment and technology segments.
Sony presents a favorable outlook with analyst consensus strongly bullish (68.75% buy ratings) and a potential 29.75% upside. Key opportunities include robust gaming and sensor divisions, but risks involve 2026 profit margin pressures, competitive threats, and execution challenges in new ventures. Investors should weigh solid cash flow and asset base against near-term earnings volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Sony Group Corp
Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.
Read more on SONY →
